©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 110087
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.110087
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.110087
Table 1 Patients demographics
| Luminal A (n = 82) | Luminal B (n = 12) | Triple neg (n = 8) | HER 2 enrich (n = 5) | P value | |
| Age at diagnosis | 59.8 ± 12.4 | 58.7 ± 11.65 | 62.2 ± 15.8 | 56.21 ± 11.0 | 0.85 |
| Metastasis-free survival (median, years) | 2.55 (0.05-7.39) | 2.75 (0.65-7.12) | 1.14 (0.09-5.98) | 0.37 (0.05-8.89) | 0.98 |
| BMI | 26.8 ± 5.9 | 24.4 ± 5.7 | 26.3 ± 4.8 | 25.4 ± 8.3 | 0.58 |
| Death | 59 (72.8%) | 9 (75%) | 8 (100%) | 3 (60%) | 0.33 |
- Citation: Zari DS, Novak R, Haviv O, Ron I, Kaplan B, Awad B, Norman D, Nikomarov D. Anatomical distribution of bone metastases in stage IV breast cancer: According to histological subtype. World J Clin Oncol 2025; 16(9): 110087
- URL: https://www.wjgnet.com/2218-4333/full/v16/i9/110087.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i9.110087